The Role of Hyperbaric Oxygen Therapy (HBOT) in Veterinary Clinics & Animal Hospitals
Veterinary clinics and animal hospitals may receive enquiries about hyperbaric oxygen therapy for animal patients. Any clinical consideration should begin with a veterinary surgeon’s assessment and take account of the animal’s diagnosis, stability, species, size, behaviour, welfare and wider care plan.
The evidence, protocols, monitoring requirements and risks can differ between species and conditions. Clinical HBOT should therefore be considered case by case and, where used, integrated with the primary veterinary pathway rather than positioned as a stand-alone solution.
Origin Oxygen products should not be assumed to be suitable for veterinary clinical use. The exact product’s certification, documentation and intended use must be verified before any role is considered.
Veterinary Clinical Context
In a veterinary setting, clinical HBOT involves controlled pressure and oxygen exposure within a managed chamber environment. The responsible veterinary surgeon determines whether there is a clinical rationale and whether the animal is stable and suitable for the proposed pathway.
The source material discusses complex wounds, tissue compromise, traumatic injury and challenging infections as contexts in which veterinary teams may evaluate HBOT. These are not universal indications, and the decision remains individual to the animal and the wider veterinary plan.
Integration with Established Veterinary Care
Where a veterinary team considers HBOT, it should complement rather than displace established assessment and care. Surgery, wound management, analgesia, infection management, imaging and rehabilitation may continue to form the main pathway according to the animal’s needs.
Species-specific handling is also important. Size, behaviour, respiratory status and tolerance can affect how a service is planned. A chamber programme therefore needs veterinary governance, trained operators and procedures appropriate to the patient population.
Safety, Welfare and Service Governance
Protocols should cover patient screening, veterinary supervision, chamber compatibility, safe handling or restraint, monitoring, emergency planning and equipment maintenance. Animal welfare and clinical stability should remain central throughout assessment and any session.
Owners should receive clear information about the purpose of the proposed service, practical handling arrangements, uncertainties and possible risks. The clinic should also have defined escalation procedures if the animal becomes distressed or a clinical concern is identified.
Evidence and Product Status
The evidence base varies between veterinary conditions and species, so broad claims should be avoided. A responsible service should have a documented clinical rationale, clear review points and realistic communication about uncertainty and individual variation.
Clinical veterinary experience or research should not be used to imply that a particular Origin Oxygen product has been assessed or approved for the same purpose. Product use and claims must remain within the exact product’s verified certification, documentation and intended use.
FAQs
Only where the practice has appropriate governance, equipment, trained staff, species-appropriate procedures, maintenance arrangements and a clear plan for monitoring, emergencies and veterinary oversight.
No. A veterinary surgeon should assess the diagnosis, wound cause, circulation, infection, stability, welfare and existing care plan before deciding whether specialist hyperbaric consideration is relevant.
No. A chamber-based pathway should not replace the primary veterinary assessment or established care. Where considered, it should be integrated with the wider plan determined by the veterinary team.
Owners should receive clear information about the proposed purpose, handling and monitoring arrangements, uncertainties, possible risks and welfare safeguards, with the opportunity to discuss questions with the responsible veterinary team.
Conclusion
A veterinary hyperbaric service requires case-by-case professional assessment, species-appropriate procedures, trained staff and strong welfare safeguards. Clinical HBOT, where considered, should remain part of a wider veterinary plan rather than a stand-alone promise. Evidence and outcomes vary, and Origin Oxygen products should only be used or described in line with their verified certification, documentation and intended use. This information is general and does not replace veterinary advice.